IMU Biosciences Partners with Waters to Advance AI Immune Mapping Platform
IMU Biosciences has selected Waters to advance its Artificial Intelligence (AI)-powered immune mapping platform, accelerating early disease diagnosis, patient monitoring, and precision medicine development.
Machine Learning (ML) | 26/06/2026 | By News Bureau | 147
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy